Release Date: 2024-06-10

Overview of Some Biochemical Parameters in Parkinson’s Disease

Veysel Tahiroglu (Author), Ilhami Gulcin (Author)

Release Date: 2024-06-10

Parkinson disease is a neurodegenerative disease that affects dopaminergic neurons in the substantia nigra. Parkinson’s disease is a disease that occurs with unwanted and uncontrolled movements, causing balance and coordination difficulties, resulting in tremor paralysis. Due to symptoms such as tremors, Parkinson disease significantly affects a person’s quality of life and can worsen if left [...]

Media Type
    Buy from

    Price may vary by retailers

    Work TypeBook Chapter
    Published inNeurological Diseases and Treatments in Terms of Biochemistry
    First Page97
    Last Page109
    DOIhttps://doi.org/10.69860/nobel.9786053359357.6
    Page Count13
    Copyright HolderNobel Tıp Kitabevleri
    Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing
    Parkinson disease is a neurodegenerative disease that affects dopaminergic neurons in the substantia nigra. Parkinson’s disease is a disease that occurs with unwanted and uncontrolled movements, causing balance and coordination difficulties, resulting in tremor paralysis. Due to symptoms such as tremors, Parkinson disease significantly affects a person’s quality of life and can worsen if left untreated. In this section, the relationship between important biochemical parameters such as dopamine, insulin resistance, vitamin D, glycemic index, cholesterol, proteins and minerals, which have very important roles in the prognosis and treatment process of Parkinson, and Parkinson’s is evaluated. We believe that clinicians can manage the disease process more efficiently and effectively by taking into account the points expressed in this section in every process of Parkinson disease.

    Veysel Tahiroglu (Author)
    Assitant Professor, Şırnak University
    https://orcid.org/0000-0003-3516-5561
    3Veysel Tahiroğluwas graduated from the Faculty of VeterinaryMedicine Faculty, Kafkas University (Kars, Turkey). He completed hisdoctorate in Medical Biochemistry at the Faculty of Medicine of KafkasUniversity (Kars, Turkey). He now serves as a Faculty member at theNursing Department, Faculty of Health Sciences, Şırnak University (Şırnak, Turkey).

    Ilhami Gulcin (Author)
    Professor, Ataturk University
    https://orcid.org/0000-0001-5993-1668
    3Prof. Dr. İlhami Gülçin is one of the leading scientists in the world with his scientific studies in the field of antioxidants. In his studies, he has brought the antioxidant potential of many natural products to the world of science. He has hundreds of international articles in this field. He is still continuing many projects on natural antioxidants. He has also trained many scientists in the field of antioxidants.

    • Nussbaum RL ve Ellis CE. Alzheimer's disease and Parkinson disease. N Engl J Med 2003; 348(14): 1356-1364.

    • Poewe W, Seppi K, Tanner CM, Halliday GM, ve ark. Parkinson disease. Nat Rev Dis Primers 2017; 3: 17013.

    • Beitz, J. M. (2014). Parkinson disease: a review. Frontiers in Bioscience-Scholar, 6(1), 65-74.

    • Khoo TK, Yarnall AJ, Duncan GW, Coleman S, ve ark. The spectrum of nonmotor symptoms in early Parkinson disease. Neurology 2013; 80(3): 276-281.

    • Kalia LV ve Lang AE. Parkinson disease. Lancet 2015; 386(9996): 896-912.

    • Dickson DW, Braak H, Duda JE, Duyckaerts C, ve ark. Neuropathological assessment of Parkinson disease: refining the diagnostic criteria. Lancet Neurol 2009; 8(12): 1150-1157.

    • Kordower JH, Olanow CW, Dodiya HB, Chu Y, ve ark. Disease duration and the integrity of the nigrostriatal system in Parkinson disease. Brain 2013; 136(Pt 8): 2419-2431.

    • Masters CL, Kril JJ, Halliday GM, Pamphlett R, ve ark. Overview and recent advances in neuropathology. Part 2: Neurodegeneration. Pathology 2011; 43(2): 93-102.

    • Goedert M, Spillantini MG, Del Tredici K ve Braak H. 100 years of Lewy pathology. Nat Rev Neurol 2013; 9(1): 13-24.

    Share This Chapter!